Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.
Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 in the page header. No substantive content changes to study details or eligibility criteria are evident from the visible page content.SummaryDifference0.1%
- Check21 days agoChange DetectedRemoved the government funding/status notice; this informational banner did not impact study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check36 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the study title, NCT number, locations, and inclusion/exclusion criteria appear unchanged.SummaryDifference0.4%
- Check64 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%
- Check71 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
- Check86 days agoChange DetectedUpdated the page to Revision: v3.0.2 and removed the 'Back to Top' item.SummaryDifference0.2%
Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.